Blockchain in counterfeit Drug Prevention
Drug counterfeiting has become a major threat to the healthcare industry. In developing countries, almost 10 percent to 30 percent of drugs are counterfeited. It has become a difficult task for the government to control drug counterfeiting as even today it is hard to find the number of patients exposed to this crime. With almost $200 billion global annual loss caused by drug counterfeiting, it has become compulsory for the pharmaceutical industry to introduce a new system to end this fatal offense.
Blockchain can efficiently modify the pharmacy supply chain. The major specialty of blockchain is that they are robust enough to perform actions that other technologies cannot. Blockchain enables users to control their data which other solutions fail to provide. Particularly, in Pharma supply chain, transparency and traceability acts as a key to Blockchain. At present, pharmaceutical industry leveraging different software’s to manage drug supplies. With the advent of Blockchain systems, each member controls a node on the network and every transaction requires a consensus which can bring transformation in the drug supply chain.
In general, pharmaceutical companies use a central database to handle their supply chains. It has system administrators who have the license to edit, modify or delete records. Whereas in Blockchain, records are stable and cannot be changed in any way possible which helps in secured data transfer preventing human errors and making it cost efficient.
Counterfeit drug prevention, controlled substance monitoring, Cold Chain monitoring and active pharmaceutical ingredients are the major significant use-cases of Blockchain in Pharma supply chain. Deploying Blockchain, organizations can improve productivity and streamline testing and drug distribution making the organization more adaptable.
By James Seevers, CIO & GM, Toyoda Gosei
By Bill Krivoshik, SVP & CIO, Time Warner Inc.
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Bruce. D. Smith, SVP & CIO, Information Systems, Advocate...
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Graham Welch, Director-Cisco Security, Cisco
By Michael Watkins, Senior Product Director, Global Knowledge
By Bernd Schlotter, President of Services, Unify
By Patrick Hale, CIO, VITAS Healthcare
By Steve Bein, VP-GIS, Michael Baker International
By Jason Alan Snyder, CTO, Momentum Worldwide
By Mike Morris, CIO, Legends
By Louis Carr, Jr., CIO, Clark County
By Bill Dow, SVP and General Manager of Business Solutions,...
By Jim Whitehurst, CEO, Red Hat
By Darren Cockrel, CIO, Coyote Logistics, a UPS Company...
By Nathan Johnson, SVP and CIO, Werner Enterprises [NASDAQ:...
By David Tamayo, CIO, DCS Corporation
By Neil Hampshire, CIO, ModusLink Global Solutions, Inc....